Artiva Biotherapeutics Inc. (ARTV)
Market Closed
12 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
8. 54
+0.54
+6.75%
$
211.08M Market Cap
- P/E Ratio
- Div Yield
1.43M Volume
- Eps
$ 8
Previous Close Investors:
Want to track ARTV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Artiva Biotherapeutics Inc. (ARTV) Statistics
Valuation metrics
Market Cap 211.08M
Enterprise value 200.39M
Trailing P/E (ttm) -2.42
Forward P/E -
PEG ratio 0.22
Price/Sales (ttm) -
Price/Book (mrq) 2.4
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.37
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.43M
Average volume (90 days) 448.73K
Price summary
52-Week low 1.47
52-Week high 14.53
Beta -
50-Day moving average 9.89
200-Day moving average 6.18
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.82%
Return on equity -0.73%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.52
Total debt (mrq) -
Total Debt/Equity (mrq) 0.12
Current ratio (mrq) 8.16%
Book value per share (mrq) 3.56
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
